SBFM logo

Sunshine Biopharma, Inc. Stock Price

NasdaqCM:SBFM Community·US$1.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 19 Fair Values set on narratives written by author

SBFM Share Price Performance

US$0.28
-1.21 (-80.93%)
US$0.28
-1.21 (-80.93%)
Price US$0.28

SBFM Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks
2 Rewards

Sunshine Biopharma, Inc. Key Details

US$35.5m

Revenue

US$23.8m

Cost of Revenue

US$11.7m

Gross Profit

US$17.7m

Other Expenses

-US$6.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-1.23
32.98%
-17.02%
0%
View Full Analysis

About SBFM

Founded
n/a
Employees
50
CEO
Steve Slilaty
WebsiteView website
sunshinebiopharma.com

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Recent SBFM News & Updates

Recent updates

No updates